Market Place
Sourcing Support
BioSenic Analyzes Phase 2 Data For Arsenic Trioxide In CGVHD Trial
18 Jul 2024 //
GLOBENEWSWIRE
Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
05 Jul 2024 //
GLOBENEWSWIRE
Medsenic Signs New Licensing Agreements With Phebra PTY Ltd
02 Jul 2024 //
GLOBENEWSWIRE
Medsenic amends licence agreement with Phebra for arsenic trioxide
30 May 2023 //
PHARMACEUTICAL TECHNOLOGY
BioSenic SA provides update on its autoimmune disease platform based on ATO
07 Nov 2022 //
GLOBENEWSWIRE
Medsenic Publishes an Article in Transplantation and Cellular Therapy
18 Jul 2022 //
BUSINESSWIRE
Drug combination an alternative leukaemia treatment to chemotherapy
12 Nov 2021 //
EUROPEANPHARMACEUTICALREVIEW
Eugia Pharma’s Generics Arsenic Trioxide Receives Approvals In US
19 Oct 2021 //
FDA
USPTO Grants Patent to Medsenic`s Arsenic Trioxide in Multiple Sclerosis
29 Sep 2021 //
BUSINESSWIRE
Syros Initiates Dosing in SY-2101, Oral Form of Arsenic Trioxide, in Leukemia
29 Sep 2021 //
BUSINESSWIRE
medac Gesellschaft für Arsenic trioxide medac Receives Approval in Europe
01 Oct 2020 //
EMA
EMA: Thumbs up for 11, down for 2 new medicines
25 Jul 2020 //
RAPS
Mylan Ireland Generic Arsenic trioxide Receives Approval in Europe
14 Apr 2020 //
EMA
Flexipharm Austrading Announces Product Update on Arsenic Trioxide Phebra
23 Mar 2020 //
PR NEWSWIRE
Global Pharmaceutical Grade Arsenic Trioxide Market 2020
03 Mar 2020 //
BCCOURIER
Xospata leads latest CHMP recommendations
21 Sep 2019 //
PHARMATIMES
EMA`s CHMP Recommends Three New Medicines
20 Sep 2019 //
RAPS
Darzalex, Ibrance among latest SMC decisions
09 Jul 2019 //
PHARMATIMES
Phebra Establishes New Subsidiary In Canada And Announces Marketing Approval
23 May 2019 //
PRESS RELEASE
Flexipharm Austrading Announces Launch of Arsenic Trioxide Phebra
20 May 2019 //
PR NEWSWIRE
STI Pharmaceuticals Generic Arsenic Trioxide Receives Approval in US
08 May 2019 //
FDA
World First Development of an Arsenic-Peptide to Target Cancer
11 Apr 2019 //
PRNASIA
Nexus Pharms Generic Arsenic Trioxide Receives Approval in US
17 Nov 2018 //
FDA
Zydus Pharms`s Generic Arsenic Trioxide Receives Approval in US
14 Nov 2018 //
FDA
Zydus Cadila gets USFDA nod for leukemia treatment injection
13 Nov 2018 //
ECONOMIC TIMES
Amring Pharms`s Generic Arsenic Trioxide Receives Approval in US
12 Nov 2018 //
FDA
Fresenius Kabi USA`s Generic Arsenic Trioxide Receives Approval in US
05 Sep 2018 //
FDA
Biohaven to begin clinical development of BHV-5000 to treat Rett syndrome
18 Jan 2018 //
PHARMABIZ
CTI BioPharma to Receive $10 Million Milestone Payment for TRISENOX®
17 Jan 2018 //
PR NEWSWIRE
Nexus Pharm’s Generic Arsenic Trioxide Receives Approval In US
20 Dec 2017 //
FDA
EC approves Teva’s Acute Promyelocytic Leukaemia drug
28 Nov 2016 //
EUROPEAN PHARMACEUTICAL
EU expands scope of Teva’s Trisenox
21 Nov 2016 //
PHARMATIMES
EMA panel recommends expansion of Teva`s Trisenox
17 Oct 2016 //
PHARMABIZ
